Heart Failure

123456789101112131415161718192021222324
Across
  1. 2. directly generates cyclic guanosine monophosphate and restores the sensitivity of soluble guanylate cyclase to endogenous nitric oxide
  2. 3. imbalance of estrogen and androgen in the male breast tissue
  3. 5. agent that alters the force or energy of muscular contractions
  4. 6. Subset III: __________ AKA Cold and Dry
  5. 10. collection of fluid inside the abdomen
  6. 11. a serious but rare adverse effect of loops diuretics
  7. 12. released from ventricle in response to increased volume in heart
  8. 13. term for enlarged heart
  9. 16. Beta blocker salt component shown to improve survival in patients with HF
  10. 17. the only heart failure medicine specifically indicated for self-identified African American patients
  11. 18. NYHA Functional Class: Mild symptoms (dyspnea, fatigue, or chest pain) with ordinary daily activities
  12. 19. Approved for use in stable, symptomatic chronic HF on maximally tolerated doses of beta-blocker therapy unless contraindicated
  13. 21. term for breathlessness or shortness of breath
  14. 23. Levels of digitalis that are 2.2 ng/ml
  15. 24. shortness of breath when lying flat
Down
  1. 1. has a boxed warning for cyanide toxicity
  2. 4. Agent with increased risk for genital mycotic infections
  3. 7. an example of an ACE inhibitor
  4. 8. Considered in patients with volume overload in the absence of symptomatic hypotension to help relieve congestion and dyspnea as an adjunct to IV diuretics
  5. 9. ultrasound of the heart
  6. 14. this chamber of the heart this pumps blood to the lungs
  7. 15. defined as a baseline EF of 40% or less with a 10-point or greater increase from baseline and a repeat EF measurement greater than 40% (abbreviation)
  8. 16. cardiac output consists of heart rate x ____ volume
  9. 20. allergic reaction involving edema of the face and airways when taking captopril
  10. 22. NNT to prevent all- cause mortality over time for MRA therapy